Results 1 to 10 of about 394,438 (273)

Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2021
Background Glioblastoma is the most aggressive primary malignant brain tumor in adults and is characterized by poor prognosis. Immune evasion occurs via programmed death-ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) interaction.
Dina Mohamed El Samman   +5 more
doaj   +1 more source

Tumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases [PDF]

open access: yesResearch in Oncology, 2022
Background: Tumor-infiltrating lymphocytes (TILs) were found to be associated with a better clinical outcome in specific subtypes of breast cancer. Aim: To study the association between TILs and the prognosis of Egyptian patients with HER2-negative ...
Elia Hakim   +4 more
doaj   +1 more source

Cytokines profile in patients with hydatidosis in Babylon Province, Iraq

open access: yesMedical Journal of Babylon, 2023
Background: Hydatidosis is caused by infection with the larval stage of the Cestode Echinococcus granulosus. Objective: In vitro quantitative evaluation of interleukin 6 (IL-6), INF-gamma (INF-γ), and CD4 and CD8 molecules during hydatidosis infection ...
Ahmed Mohammed A Al-Mosawi   +4 more
doaj   +1 more source

Bystander CD4+ T cells infiltrate human tumors and are phenotypically distinct

open access: yesOncoImmunology, 2022
Tumor-specific T cells likely underpin effective immune checkpoint-blockade therapies. Yet, most studies focus on Treg cells and CD8+ tumor-infiltrating lymphocytes (TILs).
Shamin Li   +10 more
doaj   +1 more source

Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma

open access: yesCancer Biology & Medicine, 2023
Objective: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy. CD8+ T cells, cancer stem cells (CSCs), and tumor budding (TB) have been significantly correlated with the outcome of patients with PDAC, but the correlations have been ...
Tianxing Zhou   +11 more
doaj   +1 more source

Respiratory Syncytial Virus Infection Induces Expression of Inducible Nitric Oxide Synthase, CD3, and CD8 in Naturally Occurring Pneumonia in Lambs

open access: yesActa Veterinaria, 2021
Respiratory syncytial virus (RSV) is an RNA virus that belongs to the Pneumovirus genus of the Paramyxoviridae family. The aim of this study was to evaluate the expressions of inducible nitric oxide synthetase (iNOS), CD3 (pan T cells), and CD8 ...
Yaman Turan, Aydemir Ceyhun
doaj   +1 more source

Digital image analysis for estimating stromal CD8+ tumor-infiltrating lymphocytes in lung adenocarcinoma

open access: yesJournal of Pathology Informatics, 2021
Background: Stromal CD8+ tumor-infiltrating lymphocytes (TILs) are an important prognostic and predictive indicator in non-small cell lung cancer (NSCLC).
Iny Jhun   +5 more
doaj   +1 more source

The Immunomodulatory Effects of Ginger (Zingiber officinale) Extract on CD4 and CD8 Expression in Spleen of Diabetic Rats

open access: yesNamık Kemal Tıp Dergisi, 2023
Aim:This study aims to examine the changes of the ginger extract treatment on CD4 and CD8 expressions in the spleen tissue of rats, in which the experimental diabetes was induced with streptozotocin.Materials and Methods:Forty Wistar albino rats were ...
Buket BAKIR
doaj   +1 more source

The expression of SP263 in muscle invasive bladder carcinoma and its relationship with clinicopathological features

open access: yesIndian Journal of Pathology and Microbiology, 2023
Context: The expression of programmed cell death ligand1 (PDL1) is a research hotspot of immunotherapy. The treatment targeted for its expression has shown effectiveness in many tumors. Objective: The aim of the study was to determine PD-L1 expression in
Yanfeng Bai   +6 more
doaj   +1 more source

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer

open access: yesOncoImmunology, 2021
OX40 (CD134) is a co-stimulatory molecule mostly expressed on activated T lymphocytes. Previous reports have shown that OX40 can be an immuno-oncology target and a clinical biomarker for cancers of various organs.
Hiroshi Yokouchi   +23 more
doaj   +1 more source

Home - About - Disclaimer - Privacy